|
Rovere G, Nadal-Nicolás FM, Sobrado-Calvo P, García-Bernal D, Villegas-Pérez MP, Vidal-Sanz M, Agudo-Barriuso M. Topical Treatment With Bromfenac Reduces Retinal Gliosis and Inflammation After Optic Nerve Crush. Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6098-6106. doi: 10.1167/iovs.16-20425. PubMed PMID: 27832276.
AÑO: 2016; IF: 3.303
|
27832276
|
Sánchez-Migallón MC, Valiente-Soriano FJ, Nadal-Nicolás FM, Vidal-Sanz M, Agudo-Barriuso M. Apoptotic Retinal Ganglion Cell Death After Optic Nerve Transection or Crush in Mice: Delayed RGC Loss With BDNF or a Caspase 3 Inhibitor. Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):81-93. doi: 10.1167/iovs.15-17841. PubMed PMID: 26780312.
AÑO: 2016; IF: 3.303
|
|
Rovere G, Nadal-Nicolás FM, Wang J, Bernal-Garro JM, García-Carrillo N, Villegas-Pérez MP, Agudo-Barriuso M, Vidal-Sanz M. Melanopsin-Containing or Non-Melanopsin-Containing Retinal Ganglion Cells Response to Acute Ocular Hypertension With or Without Brain-Derived Neurotrophic Factor Neuroprotection. Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6652-6661. doi: 10.1167/iovs.16-20146. PubMed PMID: 27930778.
AÑO: 2016; IF: 3.303
|
|
Nadal-Nicolás FM, Rodriguez-Villagra E, Bravo-Osuna I, Sobrado-Calvo P, Molina-Martínez I, Villegas-Pérez MP, Vidal-Sanz M, Agudo-Barriuso M, Herrero-Vanrell R. Ketorolac Administration Attenuates Retinal Ganglion Cell Death After Axonal Injury. Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1183-92. doi: 10.1167/iovs.15-18213. PubMed PMID: 26975030.
AÑO: 2016; IF: 3.303
|
|
Di Pierdomenico J, García-Ayuso D, Jiménez-López M, Agudo-Barriuso M, Vidal-Sanz M, Villegas-Pérez MP. Different Ipsi- and Contralateral Glial Responses to Anti-VEGF and Triamcinolone Intravitreal Injections in Rats. Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3533-44. doi: 10.1167/iovs.16-19618. PubMed PMID: 27379578.
AÑO: 2016; IF: 3.303
|